Lv71
3720 积分 2023-05-31 加入
Myasthenia gravis: from autoantibodies to therapy
5小时前
待确认
Treatment Outcomes of Zanubrutinib-Based Regimen in Newly Diagnosed Patients with MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Real-World Study
1个月前
已完结
Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab Vedotin
1个月前
已完结
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report
1个月前
已完结
R‐CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B‐cell lymphoma
1个月前
已完结
Rituximab in treatment of primary gastric diffuse large B-cell lymphoma
1个月前
已完结
Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan
1个月前
已完结
Mitomycin C Inhibits Ribosomal RNA
3个月前
已完结
DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells
3个月前
已完结
Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma
3个月前
已完结
皖公网安备34019202002308
